GSK plc - Dec 3, 2025 SCHEDULE 13D/A Report for CureVac N.V. Common Shares, par value (euro) 0.12 per share (CVAC)

Filing Manager: GSK plc
Reporting Manager: GSK plc
Security: CureVac N.V. Common Shares, par value (euro) 0.12 per share
Symbol: CVAC
Disclosed Ownership: 0 shares
Ownership: 0%
Form type: SCHEDULE 13D/A
Date filed: 12/5/2025, 04:23 PM
Date of event: Dec 3, 2025
Previous filing: Aug 13, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
GSK plc	0%	0	0	0	/s/ Victoria A. Whyte	Victoria A. Whyte, Authorized Signatory	0001131399